Showing results (141-150 of 190) with videos related to
Sort By:
Pageof 19
Cancers|October 23, 2020
SFCE-RAPIRI Phase I Study of Rapamycin Plus Irinotecan: A New Way to Target Intra-Tumor Hypoxia in Pediatric Refractory CancersSarah Jannier, Véronique Kemmel, Consuelo Sebastia Sancho, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2019
A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory BRAF V600 Mutation-Positive Solid TumorsMark W Kieran, Birgit Geoerger, Ira J Dunkel, et al.Frontiers in Immunology|February 6, 2024
Divergent HLA variations and heterogeneous expression but recurrent HLA loss-of- heterozygosity and common HLA-B and TAP transcriptional silencing across advanced pediatric solid cancersWan Ching Lim, Maria Eugenia Marques Da Costa, Karine Godefroy, et al.The Lancet. Oncology|July 6, 2017
From class waivers to precision medicine in paediatric oncologyAndrew D J Pearson, Stefan M Pfister, Andre Baruchel, et al.Expert Review of Anticancer Therapy|July 12, 2023
Neurotrophic tropomyosin receptor kinase (NTRK) fusion positive tumors: a historical cohort analysisLauriane Lemelle, Delphine Guillemot, Anne-Laure Hermann, et al.International Journal of Radiation Oncology, Biology, Physics|July 4, 2021
The Impact of Radiation Therapy in Children and Adolescents With Metastatic RhabdomyosarcomaAlison L Cameron, Markus C Elze, Michela Casanova, et al.The Lancet. Oncology|December 9, 2019
Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trialBirgit Geoerger, Hyoung Jin Kang, Michal Yalon-Oren, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II Sarcoma Alliance for Research through Collaboration studyAlberto S Pappo, Shreyaskumar R Patel, John Crowley, et al.European Journal of Cancer (Oxford, England : 1990)|March 18, 2020
Outcomes of metastatic non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) treated within the BERNIE study: a randomised, phase II study evaluating the addition of bevacizumab to chemotherapyAndrea Ferrari, Johannes H M Merks, Julia C Chisholm, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2017
Molecular Screening for Cancer Treatment Optimization (MOSCATO-01) in Pediatric Patients: A Single-Institutional Prospective Molecular Stratification TrialAnne C Harttrampf, Ludovic Lacroix, Marc Deloger, et al.Pageof 19